Ligand Pharmaceuticals/ US53220K5048 /

9/29/2023 9:59:58 PM	Chg. -1.67	Volume	Bid-	Ask-	High	Low
59.87USD	-2.71%	5,583 Turnover: 336,870.65	-Bid Size: -	-Ask Size: -	61.90	59.70

GlobeNewswire 3/24/2022 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Emclaire Fi...

GlobeNewswire 3/10/2022 Mindera Health™ Appoints Ted St. Martin as Chief Financial Officer

GlobeNewswire 2/22/2022 Novan Reports Full Year 2021 Financial Results and Provides Corporate Update

GlobeNewswire 2/18/2022 Organovo Welcomes New Sr. Vice President of Strategy and Business Development

GlobeNewswire 2/16/2022 AI Therapeutics Appoints Brigette Roberts, M.D., as Chief Executive Officer

GlobeNewswire 1/5/2022 Context Therapeutics® Strengthens Research & Development Team

GlobeNewswire 12/13/2021 Sermonix Pharmaceuticals Announces Poster Presentation at the 2021 San Antonio Breast Cancer Symposi...

GlobeNewswire 11/18/2021 Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

GlobeNewswire 11/15/2021 Sermonix Pharmaceuticals Closes $40 Million Series A3 Financing Round Led by Perceptive Xontogeny Ve...

Newsfile Corp 11/5/2021 SEC Wins Jury Trial Against Hedge Fund Adviser Who Ran Manipulative Short Scheme

GlobeNewswire 9/15/2021 Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...

GlobeNewswire 8/16/2021 Sermonix Pharmaceuticals Completes Enrollment of Phase 2 ELAINE 1 Randomized Clinical Trial Assessin...

GlobeNewswire 6/28/2021 Sermonix Pharmaceuticals Completes Enrollment of Phase 2 Clinical Trial Collaboration Studying Lasof...

GlobeNewswire 6/24/2021 Selecta Biosciences Appoints Industry Leader Nishan de Silva, M.D. to Board of Directors

GlobeNewswire 6/9/2021 iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmel...

GlobeNewswire 5/13/2021 Cytovia Therapeutics Expands Leadership Team

GlobeNewswire 4/21/2021 Sermonix Pharmaceuticals Project With Huntsman Cancer Institute Researcher to Investigate Potential ...

GlobeNewswire 4/5/2021 Vyant Bio Announces Newly Appointed Board of Directors

GlobeNewswire 4/1/2021 Final Results for the year ended 31 December 2020

GlobeNewswire 2/9/2021 US Capital Global Securities Launches $7MM Preferred Stock Offering for Dianomi Therapeutics, Inc.

GlobeNewswire 2/3/2021 Codexis Appoints Dr. Esther Martinborough to its Board of Directors

GlobeNewswire 1/20/2021 Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

GlobeNewswire 12/28/2020 iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer

GlobeNewswire 12/3/2020 Sermonix to Present Poster on Phase 2 Study of Lasofoxifene in Combination with Eli Lilly and Compan...

GlobeNewswire 12/2/2020 NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer